CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Ferring Pharmaceuticals Inc. v. Par Pharmaceutical Inc.

1:15-cv-00173

Overview

Case Number 1:15-cv-00173
Filing Date 2015-02-20
Status Terminated
Termination Date 2017-07-28
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

8 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Taniel E. Anderson

Email: taniel.anderson@afslaw.com

Richard J. Berman

Email: Richard.Berman@afslaw.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Janine A. Carlan

Email: janine.carlan@afslaw.com

Aziz Burgy

Email: aburgy@axinn.com

Alton L. Hare , III

Email: alton.hare@pillsburylaw.com

Ahmed Abdel-Rahman

Email: ahmed.abdelrahman@pillsburylaw.com

Plaintiff

Ferring International Center SA Operating Company

Represented By

3 Attorneys Listed

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Ferring Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

John W Cox

Email: john.cox@wbd-us.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Chittam U. Thakore

Email: thakoreC@ballardspahr.com

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): CN 🇪🇺 Europe GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8450338
Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
Filed: 2011-09-27
Issued: 2013-05-28
Active (1.9 yrs remaining)
Expires: 2028-10-19
US8481083
Granular compositions of magnesium oxide and citric acid and uses thereof
Filed: 2008-10-10
Issued: 2013-07-09
Active (1.9 yrs remaining)
Expires: 2028-10-10

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

32

Dispositive

0

Granted

0

Denied

0

Pending / Review

21

Motions by Category

Claim Construction / Markman Filing 11 Procedural / Extension Motion 21

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 213 STIPULATION TO EXTEND TIME to file response and reply to Motion for Attorneys' Fees (*Reset Briefing Schedule: re 210 MOTION for Attorney Fee...
Entry #— • 2018-08-24
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Par Pharmaceutical, Inc. to file response to Plaintiffs' Motion for Attorneys' Fees and for Plaintiffs to file reply br...
Entry #213 • 2018-08-23 Document →
Procedural / Extension Motion Pending / Under Review
SO ORDERED, re 203 STIPULATION TO EXTEND TIME for Plaintiffs to file a motion for attorneys' fees to date set forth in the Stipulation. Signed by Judge Richard ...
Entry #204 • 2017-08-21 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file a motion for attorneys' fees to date set forth in the Stipulation - filed by Ferring International Center SA, ...
Entry #203 • 2017-08-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file a motion for attorneys' fees and nonrelated taxable expenses to August 18, 2017 - filed by Ferring Internation...
Entry #199 • 2017-08-10 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 199 STIPULATION TO EXTEND TIME to file a motion for attorneys' fees and nonrelated taxable expenses to August 18, 2017. Signed by Judge Richard G...
Entry #— • 2017-08-10

Docket Entries

(298 total)
Pleading / Complaint

COMPLAINT - filed against Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1677894.) - filed by Ferring Pharmaceuticals Inc., Ferring International Center SA. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(rwc) (Entered: 02/20/2015)

Entry #1 • 2015-02-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 02/20/2015)

Entry #2 • 2015-02-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/12/15. Date of Expiration of Patent: 10/10/28.Thirty Month Stay Deadline: 7/12/2017. (rwc) (Entered: 02/20/2015)

Entry #3 • 2015-02-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083. (rwc) (Entered: 02/20/2015)

Entry #4 • 2015-02-20
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ferring BV, Corporate Parent Ferring Holding Inc., Corporate Parent Ferring Holding SA for Ferring Pharmaceuticals Inc. filed by Ferring International Center SA, Ferring Pharmaceuticals Inc.. (rwc) (Entered: 02/20/2015)

Entry #5 • 2015-02-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc